| Condensed consolidated balance sheets at December 31, 2001 (audited) and September 30, 2002 (unaudited)
|
| Unaudited condensed consolidated statements of operations for the nine months ended September 30, 2001 and
2002 |
| Unaudited condensed consolidated statement of shareholders equity and comprehensive income for the nine months
ended September 30, 2002 |
| Unaudited condensed consolidated statements of cash flows for the nine months ended September 30, 2001 and
2002 |
| Notes to unaudited condensed consolidated financial statements |
| December 31, 2001 (audited) |
September 30, 2002
(unaudited) |
|||||||
| (in thousands) |
||||||||
| ASSETS |
||||||||
| Current assets |
||||||||
| Cash and cash equivalents |
$ |
121,503 |
|
$ |
108,271 |
| ||
| Short term investmentsavailable for sale |
|
1,800 |
|
|
|
| ||
| Accounts receivable |
|
3,541 |
|
|
6,022 |
| ||
| Prepayments and other current assets |
|
3,365 |
|
|
3,851 |
| ||
| Inventory |
|
797 |
|
|
341 |
| ||
| |
|
|
|
|
| |||
| Total current assets |
|
131,006 |
|
|
118,485 |
| ||
| Property, plant and equipment, net |
|
7,691 |
|
|
6,264 |
| ||
| Investments |
|
|
|
|
4,500 |
| ||
| Goodwill, net |
|
62,691 |
|
|
63,579 |
| ||
| Intangible assets, net |
|
4,432 |
|
|
3,412 |
| ||
| |
|
|
|
|
| |||
| Total assets |
$ |
205,820 |
|
$ |
196,240 |
| ||
| |
|
|
|
|
| |||
| LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||
| Current liabilities |
||||||||
| Accounts payable |
$ |
5,672 |
|
$ |
4,619 |
| ||
| Accrued liabilities |
|
11,178 |
|
|
15,843 |
| ||
| Deferred revenue |
|
4,759 |
|
|
2,456 |
| ||
| Taxes payable |
|
2,124 |
|
|
1,684 |
| ||
| |
|
|
|
|
| |||
| Total current liabilities |
|
23,733 |
|
|
24,602 |
| ||
| Shareholders equity |
||||||||
| Ordinary shares, par value 0.000317 per share; 8,000,000,000 shares authorized at December 31, 2001 and September 30, 2002;
581,180,431 and 593,303,271 shares issued and outstanding at December 31, 2001 and September 30, 2002 |
|
205 |
|
|
208 |
| ||
| Additional paid in capital |
|
239,138 |
|
|
241,327 |
| ||
| Deferred stock compensation |
|
(5,052 |
) |
|
(3,477 |
) | ||
| Accumulated other comprehensive income |
|
(3,065 |
) |
|
(3,036 |
) | ||
| Retained earnings |
|
(49,139 |
) |
|
(63,384 |
) | ||
| |
|
|
|
|
| |||
| Total shareholders equity |
|
182,087 |
|
|
171,638 |
| ||
| |
|
|
|
|
| |||
| Total liabilities and shareholders equity |
$ |
205,820 |
|
$ |
196,240 |
| ||
| |
|
|
|
|
| |||
| Nine months ended September 30, |
||||||||
| 2001 |
2002 |
|||||||
| (in thousands except share and
per share data ) |
||||||||
| Revenue |
||||||||
| IP license |
$ |
21,261 |
|
$ |
27,391 |
| ||
| IP creation |
|
5,558 |
|
|
1,859 |
| ||
| Hard IP |
|
3,586 |
|
|
1,785 |
| ||
| |
|
|
|
|
| |||
| Total revenue |
|
30,405 |
|
|
31,035 |
| ||
| |
|
|
|
|
| |||
| Cost of revenue |
||||||||
| IP license |
|
3,550 |
|
|
4,176 |
| ||
| IP creation |
|
3,907 |
|
|
1,304 |
| ||
| Hard IP |
|
1,946 |
|
|
961 |
| ||
| |
|
|
|
|
| |||
| Total cost of revenue |
|
9,403 |
|
|
6,441 |
| ||
| |
|
|
|
|
| |||
| Gross margin |
|
21,002 |
|
|
24,594 |
| ||
| Research and development |
|
21,913 |
|
|
18,841 |
| ||
| Sales and marketing |
|
8,254 |
|
|
6,442 |
| ||
| General and administrative |
|
5,573 |
|
|
4,515 |
| ||
| Amortization of goodwill & intangible assets |
|
5,385 |
|
|
1,020 |
| ||
| In process research & development charge |
|
10,895 |
|
|
|
| ||
| Loss on disposal of facility |
|
|
|
|
213 |
| ||
| ParthusCeva merger costs |
|
|
|
|
5,645 |
| ||
| Restructuring charge |
|
|
|
|
3,788 |
| ||
| |
|
|
|
|
| |||
| Total operating expenses |
|
52,020 |
|
|
40,464 |
| ||
| Loss from operations |
|
(31,018 |
) |
|
(15,870 |
) | ||
| Interest income |
|
5,053 |
|
|
1,828 |
| ||
| Foreign exchange loss |
|
(198 |
) |
|
(203 |
) | ||
| Minority interest |
|
(100 |
) |
|
|
| ||
| |
|
|
|
|
| |||
| Loss before provision for income taxes |
|
(26,263 |
) |
|
(14,245 |
) | ||
| Provision for income taxes |
|
(300 |
) |
|
( |
) | ||
| |
|
|
|
|
| |||
| Net loss available to ordinary shareholders |
$ |
(26,563 |
) |
$ |
(14,245 |
) | ||
| |
|
|
|
|
| |||
| Net loss per ordinary share |
||||||||
| Basic and diluted |
$ |
(0.048 |
) |
$ |
(0.024 |
) | ||
| |
|
|
|
|
| |||
| Weighted average number of ordinary shares outstanding |
||||||||
| Basic and diluted |
|
551,903,475 |
|
|
586,102,070 |
| ||
| |
|
|
|
|
| |||
| Number of Ordinary
Shares |
Amount |
Additional Paid-in Capital |
Deferred Stock Compensation |
Accumulated Other Comprehensive Income |
Retained Earnings |
Total Share-
holders Equity |
|||||||||||||||||||
| (in thousands, except share data) |
|||||||||||||||||||||||||
| Balance at December 31, 2001 |
581,180,431 |
$ |
205 |
$ |
239,138 |
|
$ |
(5,052 |
) |
$ |
(3,065 |
) |
$ |
(49,139 |
) |
$ |
182,087 |
| |||||||
| Comprehensive income: |
|||||||||||||||||||||||||
| Net loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
(14,245 |
) |
|
(14,245 |
) | |||||||
| Currency translation adjustment |
|
|
|
|
|
|
|
|
|
|
29 |
|
|
|
|
|
29 |
| |||||||
| Total comprehensive income |
|
(14,216 |
) | ||||||||||||||||||||||
| Exercise of share options |
8,847,271 |
|
2 |
|
994 |
|
|
|
|
|
|
|
|
|
|
|
996 |
| |||||||
| Issue of ordinary shares |
3,275,569 |
|
1 |
|
1,215 |
|
|
|
|
|
|
|
|
|
|
|
1,216 |
| |||||||
| Share issuance costs |
|
|
|
|
(20 |
) |
|
|
|
|
|
|
|
|
|
|
(20 |
) | |||||||
| Stock compensation expense |
|
|
|
|
|
|
|
1,575 |
|
|
|
|
|
|
|
|
1,575 |
| |||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
| Balance at September 30, 2002 |
593,303,271 |
$ |
208 |
$ |
241,327 |
|
$ |
(3,477 |
) |
$ |
(3,036 |
) |
$ |
(63,384 |
) |
$ |
171,638 |
| |||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
| Nine months ended September 30, |
||||||||
| 2001 |
2002 |
|||||||
| (in thousands) |
||||||||
| Cash flows from operating activities |
||||||||
| Net loss |
$ |
(26,563 |
) |
$ |
(14,245 |
) | ||
| Adjustments to reconcile net loss to net cash used in operating activities |
||||||||
| Loss on disposal of facility |
|
|
|
|
213 |
| ||
| Gain on disposal of assets |
|
(3 |
) |
|
|
| ||
| Depreciation |
|
1,976 |
|
|
2,307 |
| ||
| Amortization of goodwill and intangible assets |
|
5,385 |
|
|
1,020 |
| ||
| In-process research and development charge |
|
10,895 |
|
|
|
| ||
| Undistributed earnings of minority interest |
|
100 |
|
|
|
| ||
| Unrealized foreign exchange (gains) losses |
|
(884 |
) |
|
315 |
| ||
| Non-cash stock compensation expense |
|
1,282 |
|
|
1,575 |
| ||
| Changes in assets and liabilities |
||||||||
| Increase in accounts receivable |
|
(1,260 |
) |
|
(2,017 |
) | ||
| Decrease/(increase) in prepayments and other current assets |
|
1,657 |
|
|
(822 |
) | ||
| Decrease in inventory |
|
232 |
|
|
464 |
| ||
| (Decrease)/increase in accrued liabilities |
|
(844 |
) |
|
5,106 |
| ||
| Increase (decrease) in deferred revenue |
|
1,422 |
|
|
(2,349 |
) | ||
| Increase (decrease) in taxes payable |
|
857 |
|
|
(459 |
) | ||
| Increase (decrease) in accounts payable |
|
1,453 |
|
|
(836 |
) | ||
| |
|
|
|
|
| |||
| Net cash used in operating activities |
|
(4,295 |
) |
|
(9,728 |
) | ||
| Cash flows from investing activities |
||||||||
| Purchase of fixed assets |
|
(4,785 |
) |
|
(1,436 |
) | ||
| Sale of fixed assets |
|
3 |
|
|
|
| ||
| Disposal of facility |
|
|
|
|
(445 |
) | ||
| Purchase of business and intangible assets |
|
(25,108 |
) |
|
|
| ||
| Cash acquired with subsidiary undertaking |
|
1,061 |
|
|
|
| ||
| Sale of short term investments |
|
|
|
|
1,800 |
| ||
| Other investments |
|
|
|
|
(4,500 |
) | ||
| |
|
|
|
|
| |||
| Net cash used in investing activities |
|
(28,829 |
) |
|
(4,581 |
) | ||
| Cash flows from financing activities |
||||||||
| Proceeds from issuance of share capital |
|
1,678 |
|
|
949 |
| ||
| Share issuance costs |
|
(762 |
) |
|
(20 |
) | ||
| |
|
|
|
|
| |||
| Net cash provided by financing activities |
|
916 |
|
|
929 |
| ||
| Effect of exchange rate movements on cash |
|
(589 |
) |
|
148 |
| ||
| |
|
|
|
|
| |||
| Net decrease in cash and cash equivalents |
|
(32,797 |
) |
|
(13,232 |
) | ||
| Cash and cash equivalents at beginning of period |
|
159,865 |
|
|
121,503 |
| ||
| |
|
|
|
|
| |||
| Cash and cash equivalents at end of period |
$ |
127,068 |
|
$ |
108,271 |
| ||
| |
|
|
|
|
| |||
| Nine months ended September 30, | ||||
| 2001 |
2002 | |||
| Weighted average number of ordinary shares outstanding for basic net loss per ordinary share |
551,903,475 |
586,102,070 | ||
| Effect of dilutive share options outstanding |
|
| ||
| |
| |||
| Weighted average number of ordinary shares for diluted net loss per ordinary share |
551,903,475 |
586,102,070 | ||
| |
| |||
| Nine months ended September 30, | ||||||
| Revenue by destination |
2001 |
2002 | ||||
| (in thousands) | ||||||
| United States |
$ |
14,248 |
$ |
15,399 | ||
| Europe, Middle East and Africa |
|
12,832 |
|
12,940 | ||
| Asia |
|
3,325 |
|
2,696 | ||
| |
|
|
| |||
| Total |
$ |
30,405 |
$ |
31,035 | ||
| |
|
|
| |||
| Nine months ended September 30, 2001 |
||||
| Reported net loss: |
$ |
(26,563 |
) | |
| Add back goodwill amortization |
|
4,315 |
| |
| |
|
| ||
| Adjusted net income |
$ |
(22,248 |
) | |
| |
|
| ||
| Basic and diluted net loss per ordinary share: |
||||
| Reported |
$ |
(0.048 |
) | |
| Add back goodwill amortization |
$ |
0.008 |
| |
| |
|
| ||
| Adjusted net loss per ordinary share |
$ |
(0.040 |
) | |
| |
|
| ||